HomeCompareSKKAF vs MRK

SKKAF vs MRK: Dividend Comparison 2026

SKKAF yields 1.21% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SKKAF wins by $3.25M in total portfolio value· pulled ahead in Year 4
10 years
SKKAF
SKKAF
● Live price
1.21%
Share price
$66.37
Annual div
$0.80
5Y div CAGR
92.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.31M
Annual income
$2,691,913.10
Full SKKAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SKKAF vs MRK

📍 SKKAF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSKKAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SKKAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SKKAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SKKAF
Annual income on $10K today (after 15% tax)
$102.52/yr
After 10yr DRIP, annual income (after tax)
$2,288,126.14/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SKKAF beats the other by $2,279,797.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SKKAF + MRK for your $10,000?

SKKAF: 50%MRK: 50%
100% MRK50/50100% SKKAF
Portfolio after 10yr
$1.68M
Annual income
$1,350,855.62/yr
Blended yield
80.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SKKAF
No analyst data
Altman Z
5.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SKKAF buys
0
MRK buys
0
No recent congressional trades found for SKKAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSKKAFMRK
Forward yield1.21%2.76%
Annual dividend / share$0.80$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR92.9%32.7%
Portfolio after 10y$3.31M$56.8K
Annual income after 10y$2,691,913.10$9,798.13
Total dividends collected$3.23M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SKKAF vs MRK ($10,000, DRIP)

YearSKKAF PortfolioSKKAF Income/yrMRK PortfolioMRK Income/yrGap
1$10,933$232.67$11,206$366.19$273.00MRK
2$12,157$458.57$12,650$502.35$493.00MRK
3$13,927$919.26$14,407$694.19$480.00MRK
4← crossover$16,800$1,898.57$16,585$967.82+$215.00SKKAF
5$22,105$4,128.96$19,342$1,363.89+$2.8KSKKAF
6$33,447$9,794.19$22,913$1,947.19+$10.5KSKKAF
7$62,504$26,716.32$27,662$2,823.89+$34.8KSKKAF
8$156,888$90,008.11$34,159$4,173.35+$122.7KSKKAF
9$575,165$407,295.06$43,337$6,308.80+$531.8KSKKAF
10$3,307,340$2,691,913.10$56,776$9,798.13+$3.25MSKKAF

SKKAF vs MRK: Complete Analysis 2026

SKKAFStock

Sk Kaken Co.,Ltd. manufactures and sells organic and inorganic water-based coating materials, synthetic resin paints, inorganic coating materials, and inorganic building materials in Japan and internationally. It is also involved in the contracting of special finishing works and fireproof insulation works; and manufacture and sale of heat insulation materials, fireproof coating materials, and fireproof paints, as well as various chemical products. In addition, the company's products include exterior finishes, top coating materials, interior finishes, roof paints, iron paints, floor coverings, rooftop waterproofing materials, base adjustment coating materials, fireproof coating/insulation materials. The company was formerly known as Shikoku Kaken Industry Co., Ltd. and changed its name to Sk Kaken Co.,Ltd. in April 1991. Sk Kaken Co.,Ltd. was founded in 1955 and is headquartered in Ibaraki, Japan.

Full SKKAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SKKAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SKKAF vs SCHDSKKAF vs JEPISKKAF vs OSKKAF vs KOSKKAF vs MAINSKKAF vs JNJSKKAF vs ABBVSKKAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.